Healthcare ❯ Vaccination

COVID-19 Vaccines

Effectiveness Efficacy Booster Shots Public Health Recommendations Variants Eligibility Public Health Recommendations Vaccine Effectiveness Vaccine Efficacy Paxlovid FDA Approval Guidelines CDC Recommendations Public Health Response Access Issues Access Programs JN.1 Variant Vaccine Development Campaigns Preventive Measures Variant Adaptation mRNA Vaccines Public Health Campaigns Public Response Vaccine Side Effects Mandates Vaccine Recommendations FDA Recommendations Pfizer and Moderna Pregnancy Public Health Policy

Fungal Mycelium Supplement Tied to Fewer COVID-19 Vaccine Side Effects and Longer Antibody Response

UC San Diego’s small randomized trial reports safety with durability signals in need of larger confirmation.

Most Americans Trust Childhood Vaccines as Partisan Splits Persist, CDC Guidance Goes Largely Unnoticed

Study Links COVID in Pregnancy to Higher Neurodevelopmental Diagnoses by Age 3

Stratus Variant Drives California COVID Wave as FDA Limits New Vaccine to High-Risk Patients

U.S. Summer COVID Wave Grows as HHS Limits Fall Booster Eligibility

Nimbus COVID Variant Drives 55% of Cases in California

Kennedy Removes COVID Vaccine for Children, Pregnant Women After Flawed MAHA Report

New COVID-19 Variant NB.1.8.1 Reaches Multiple U.S. States as Vaccine Guidelines Change

New COVID Variant NB.1.8.1 Monitored in U.S. After Driving Surges in Asia